X4 Pharmaceuticals

XFOR NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $0 $0 $0
Gross Profit -62 -62 -502 -516
EBITDA -37,227 -25,137 -25,705 -25,805
EBIT -37,289 -25,199 -25,809 -25,931
Net Income -51,766 -19,130 -2,305 -55,712
Net Change In Cash 0 0 0 0
Cost of Revenue 43,029
Free Cash Flow -33,656 -27,782 -20,836 -21,433
Cash 60,493 99,466 131,581 136,428
Basic Shares 199,991 198,766 196,988 168,738

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $3,000
Gross Profit -1,996 -1,994 -1,892 3,000
EBITDA -105,526 -88,587 -65,591 -59,523
EBIT -107,522 -87,569 -85,107 -59,874
Net Income -101,167 -93,867 -88,696 -62,131
Net Change In Cash 0 0 0 3,000
Cost of Revenue 40,025 -47,786
Free Cash Flow -96,572 -77,205 -71,520 -60,180
Cash 99,466 121,718 81,787 78,708
Basic Shares 177,812 63,526 25,749 20,077

Earnings Calls

Quarter EPS
2024-03-31 -$0.26
2023-12-31 -$0.10
2023-09-30 -$0.01
2023-06-30 -$0.33